Cas:270249-38-2 2′-Methoxykurarinone manufacturer & supplier

Chemical Name:2′-Methoxykurarinone

CAS.NO:270249-38-2

Synonyms:4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxy-2-methoxyphenyl)-5-methoxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-, (2S)-;(2S)-7-Hydroxy-2-(4-hydroxy-2-methoxyphenyl)-8-[(2R)-2-isopropenyl-5-methyl-4-hexen-1-yl]-5-methoxy-2,3-dihydro-4H-chromen-4-one;Kurarinone, 2′-O-methyl-;2′-Methoxykurarinone

Molecular Formula:C₂₇H₃₂O₆

Molecular Weight:452.539

HS Code:

Physical and Chemical Properties:

Melting point:112-115 ºC

Boiling point:643.6±55.0 °C at 760 mmHg

Density:1.171±0.06 g/cm3 (20 ºC 760 Torr)

Index of Refraction:1.575

PSA:85.22000

Exact Mass:452.219879

LogP:7.05

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxy-2-methoxyphenyl)-5-methoxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-, (2S)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2′-Methoxykurarinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-7-Hydroxy-2-(4-hydroxy-2-methoxyphenyl)-8-[(2R)-2-isopropenyl-5-methyl-4-hexen-1-yl]-5-methoxy-2,3-dihydro-4H-chromen-4-one Use and application,2′-Methoxykurarinone technical grade,usp/ep/jp grade.

Related News: For category of products which involve fermentation technologies, incentive is 20 per cent of the approved sales price. The government has put a cap of Rs. 10 crore per product per annum for five years. This is a seven year scheme from 2023-24 going up to 2029-30. Chloromethyl benzoate manufacturers By integrating biocatalysis into ongoing and newly launched projects, Wavelength Pharmaceuticals has shown that it is possible to reduce overall costs by as much as 30%. 3-(aminomethyl)cyclohexan-1-ol suppliers And finally, CHMP also concluded its investigation into bluebird bio’s Zynteglo, finding no evidence that it causes a blood cancer known as acute myeloid leukemia. 3-Nitro-1H-pyrazole-4-carbonitrile vendor & factory Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY.,And finally, CHMP also concluded its investigation into bluebird bio’s Zynteglo, finding no evidence that it causes a blood cancer known as acute myeloid leukemia.